PolyNovo (ASX:PNV) said its synthetic dermal scaffold, NovoSorb MTX (up to 6mm), received US Food and Drug Administration 510(k) clearance, broadening its use in plastic and reconstructive surgery, according to a Wednesday filing with the Australian bourse.
Additionally, NovoSorb MTX (up to 2mm) received approval to be sold and marketed in Australia and approval to be imported into India, the filing said.